WHO panel supports adapted vaccine as booster against omicron
A modified vaccine against coronavirus targeting the omicron variant can be administered as booster dose to extend immunity, he considered a technical advisory group created by the World Health Organization.
The variant-adapted vaccine may benefit those who have already received the primary series of injectionssaid the agency’s panel on COVID-19 Vaccine Composition, citing available data.
The agency could consider using the vaccines globally once it obtains emergency use authorization or approval from a regulatory authority in a country with strict health indicators.
Vaccine manufacturers, including Moderna and Pfizerare developing a next generation reinforcement targeting both the omicron variant like the original strain of the coronavirus.
Moderna said last week that a new version of its vaccine produced a better immune responseagainst micron than the original vaccine, while the European Medicines Agency this week began reviews of vaccines adapted to Moderna and Pfizer variants.
COVID-19 cases increase in South America
The cases of COVID-19 in the Americasincreased 11% last week compared to the previouswith 1.2 million new cases and 4,069 new deaths, said the Pan American Health Organization (PAHO) at a press conference on June 15.
South America recorded the largest increase in cases, with an increase of 20%, while in Central America both infections and deaths fell by 32%, said PAHO. In the previous PAHO report, from June 1, Central America had registered the highest increase in deaths related to COVID.
In USA, there was a 2% increase in hospitalizations and a 4.2% increase in ICU admissions for the seventh consecutive week. In MexicoThey registered more than 31,000 cases, which is an increase of 71%said Dr. Carissa Etienne, director of PAHO.
In the Caribbean, cases increased 3.7%, while deaths decreased 19% compared to the previous week. In the 22 countries and territories with available data in the Americas, nine countries reported increases in hospitalizations for COVID-19, Etienne said.
(With information from Reuters)